Faraz Ali
Chief Executive Officer bei TENAYA THERAPEUTICS, INC.
Vermögen: 101 091 $ am 31.03.2024
Aktive Positionen von Faraz Ali
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TENAYA THERAPEUTICS, INC. | Director/Board Member | 01.09.2018 | - |
Chief Executive Officer | 01.06.2018 | - | |
Corporate Secretary | 01.06.2018 | - | |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Director/Board Member | 01.01.2023 | - |
Karriereverlauf von Faraz Ali
Ehemalige bekannte Positionen von Faraz Ali
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
REGENXBIO INC. | Corporate Officer/Principal | 01.02.2016 | 05.01.2018 |
BLUEBIRD BIO, INC. | Corporate Officer/Principal | 01.05.2011 | 01.02.2016 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.08.2001 | 01.11.2010 |
Ausbildung von Faraz Ali
Stanford University | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
REGENXBIO INC. | Health Technology |
BLUEBIRD BIO, INC. | Health Technology |
TENAYA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |